Elotuzumab in combination with thalidomide and low-dose dexamethasone: a phase 2 single-arm safety study in patients with relapsed/refractory multiple myeloma

1. Mateos, M.-V.
2. Granell, M.
3. Oriol, A.
4. Martinez-Lopez, J.
5. Blade, J.
6. Hernandez, M.T.
7. Martín, J.
8. Gironella, M.
9. Lynch, M.
10. Bleickardt, E.
11. Paliwal, P.
12. Singhal, A.
13. San-Miguel, J.